In the present study, plasma exosomes, which were bilayer vesicles with a diameter of approximately 60-100 nm containing the exosome markers (CD63 and Alix), were first efficiently extracted from the AML patient and the healthy donor (HD) by a membrane-based affinity binding kit. This evidence concerns the gene CD63 and acute myeloid leukemia.